BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON: Form 990, tax year 2014

View the entire original 990 at ProPublica ↗

Organization: BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON (EIN 91-0653422)
Tax period: 2014-01-01 to 2014-12-31
Filed: 2015-11-12
IRS object ID: 201503169349301715
Schema version: 2014v5.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule K
Schedule M
Schedule O
Schedule R
Affiliated Group Schedule

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2015-11-12T08:32:47-00:00	ReturnTs
Tax Period End	2014-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	KPMG LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	1918 8th Avenue Suite 2900	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98101	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2014-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	910653422	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	Benaroya Research Institute at Virginia Mason	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	BENA	BusinessNameControlTxt
Phone	2063426500	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 Ninth Avenue	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	981012795	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	Homer W Lane Jr	PersonNm
Person Title	Executive DirectorCFO	PersonTitleTxt
Signature	2015-11-03	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	Sue Robison	PreparerPersonNm
Phone	2069134000	PhoneNum

Field	Value	IRS element (for citing)
Tax	2014	TaxYr
Build TS	2016-02-25 16:41:14Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	Gerald Nepom MD PhD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 Ninth Avenue	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98101	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$61,520,797	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	http://www.benaroyaresearch.org	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1956	FormationYr
Legal Domicile State	WA	LegalDomicileStateCd
Activity Or Mission	To conduct and encourage high quality medical, surgical, and scientific research and research training in disease and problems of medical importance.	ActivityOrMissionDesc
Voting Members Governing Body	20	VotingMembersGoverningBodyCnt
Voting Members Independent	15	VotingMembersIndependentCnt
Total Employee	328	TotalEmployeeCnt
Total Volunteers	9	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
PY Contributions Grants	$44,973,133	PYContributionsGrantsAmt
CY Contributions Grants	$54,174,085	CYContributionsGrantsAmt
PY Program Service Revenue	$6,122,655	PYProgramServiceRevenueAmt
CY Program Service Revenue	$6,639,555	CYProgramServiceRevenueAmt
PY Investment Income	$88,984	PYInvestmentIncomeAmt
CY Investment Income	$164,405	CYInvestmentIncomeAmt
PY Other Revenue	$346,008	PYOtherRevenueAmt
CY Other Revenue	$350,163	CYOtherRevenueAmt
PY Total Revenue	$51,530,780	PYTotalRevenueAmt
CY Total Revenue	$61,328,208	CYTotalRevenueAmt
PY Grants And Similar Paid	$6,179,570	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$17,599,162	CYGrantsAndSimilarPaidAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$23,665,207	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$25,135,170	CYSalariesCompEmpBnftPaidAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$0	CYTotalFundraisingExpenseAmt
PY Other Expenses	$15,546,338	PYOtherExpensesAmt
CY Other Expenses	$19,170,074	CYOtherExpensesAmt
PY Total Expenses	$45,391,115	PYTotalExpensesAmt
CY Total Expenses	$61,904,406	CYTotalExpensesAmt
PY Revenues Less Expenses	$6,139,665	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	-$576,198	CYRevenuesLessExpensesAmt
Total Assets BOY	$82,770,690	TotalAssetsBOYAmt
Total Assets EOY	$85,390,333	TotalAssetsEOYAmt
Total Liabilities BOY	$40,055,412	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$43,346,845	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$42,715,278	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$42,043,488	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	See Schedule O	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$18,890,380	ExpenseAmt
Grant	$13,183,705	GrantAmt
Desc	Immune Tolerance Network Program. See Schedule O.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$12,047,182	ExpenseAmt
Grant	$2,736,119	GrantAmt
Desc	Translational Program. See Schedule O.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$6,169,555	ExpenseAmt
Grant	$428,014	GrantAmt
Desc	Diabetes Program. See Schedule O.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$14,382,847	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$1,251,324	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$6,639,555	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$51,489,964	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Temp Or Permanent Endowments	Yes (true)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	Yes (true)	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	false	ReportOtherAssetsInd
Report Other Liabilities	false	ReportOtherLiabilitiesInd
Include FIN48 Footnote	false	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (true)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	false	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	Yes (true)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	false	ProfessionalFundraisingInd
Fundraising Activities	false	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	false	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	Yes (true)	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	false	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	Yes (true)	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	false	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	false	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	false	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	90	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	328	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	false	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	false	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	false	QuidProQuoContributionsInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	20	GoverningBodyVotingMembersCnt
Independent Voting Member	15	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	Yes (true)	MembersOrStockholdersInd
Election Of Board Members	Yes (true)	ElectionOfBoardMembersInd
Decisions Subject To Approva	Yes (true)	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	Homer W Lane Jr Executive DirectorC	PersonNm
Phone	2063426508	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 Ninth Avenue	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	981012795	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (26 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	OfficerOfficerInd	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Highest Compensated EmployeeHighestCompensatedEmployeeInd
Carla Greenbaum MD
Director	040.00	Yes (X)	$211,149	$0	$29,898
Gerald Nepom MD PhD
Ex Officio, Director	040.00	Yes (X)	$512,545	$0	$43,088	Yes (X)
Joyce Lammert MD PhD
Director	001.00	Yes (X)	$0	$580,352	$122,566		050.00
John Corman MD
Director	001.00	Yes (X)	$0	$484,030	$68,007		050.00
Gary Kaplan MD
Director	001.00	Yes (X)	$0	$1,470,727	$2,092,430		054.00
Tom Cohen
Director	001.00	Yes (X)	$0	$0	$0
Rebecca Campbell
Director	001.00	Yes (X)	$0	$0	$0
Kristi Pangrazio
Director, Chairman	001.00	Yes (X)	$0	$0	$0	Yes (X)
Margaret Morrow
Director, Secretary	001.00	Yes (X)	$0	$0	$0	Yes (X)
Steven Gillis PhD
Director	001.00	Yes (X)	$0	$0	$0
Frank Dvorak PhD
Director	001.00	Yes (X)	$0	$0	$0
Trish Markey
Director	001.00	Yes (X)	$0	$0	$0
Edward Drosdick
Director, Treasurer	001.00	Yes (X)	$0	$0	$0	Yes (X)
David Williams
Director	001.00	Yes (X)	$0	$0	$0
Ditman Johnson
Director	001.00	Yes (X)	$0	$0	$0
Michael Gallatin
Director	001.00	Yes (X)	$0	$0	$0
Jessica Muffett
Director	001.00	Yes (X)	$0	$0	$0
Carla DewBerry
Director, Vice-Chair	001.00	Yes (X)	$0	$0	$0	Yes (X)
Ann Sobil
Director	001.00	Yes (X)	$0	$0	$0
Christopher Wilson MD
Director	001.00	Yes (X)	$0	$0	$0
Homer Lane Jr
Executive Director and Chief Financial Officer	040.00		$319,692	$0	$21,394	Yes (X)
Jane Buckner MD
Research Member	040.00		$225,896	$0	$25,892			Yes (X)
William Kwok PhD
Research Member	040.00		$207,910	$0	$28,652			Yes (X)
Steven Ziegler PhD
Research Member	040.00		$178,278	$0	$23,396			Yes (X)
Thomas Wight PhD
Research Member	040.00		$161,933	$0	$37,808			Yes (X)
Lynn Rose PhD
Director Scientific Administration	040.00		$175,329	$0	$23,134			Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$1,992,732	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$2,535,109	TotReportableCompRltdOrgAmt
Total Other Compensation	$2,516,265	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	36	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (4 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
KPMG LLP
1918 Eighth Ave Suite 2900	Seattle	WA	98101	Auditing Consulting	$113,972
DNA Brand Mechanics
1301 Fifth Ave Suite 2600	Seattle	WA	98101	Consulting	$180,865
Aspect Software Inc
PO Box 894675	Los Angeles	CA	90189	Consulting	$122,705
Insight Global LLC
PO Box 198226	GA	GA	30384	Consulting	$106,178

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	4	CntrctRcvdGreaterThan100KCnt
Related Organizations	$5,075,000	RelatedOrganizationsAmt
Government Grants	$42,166,205	GovernmentGrantsAmt
All Other Contributions	$6,932,880	AllOtherContributionsAmt
Noncash Contributions	$147,625	NoncashContributionsAmt
Total Contributions	$54,174,085	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
Commercial Studies	621500	$3,412,077	$3,412,077
Core services	621500	$3,227,478	$3,227,478

Field	Value	IRS element (for citing)
Total Program Service Revenue	$6,639,555	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$164,405	TotalRevenueColumnAmt
Exclusion	$164,405	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$542,752	RealAmt

Less Rental Expenses LessRentalExpensesGrp

Field	Value	IRS element (for citing)
Real	$192,589	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$350,163	RealAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$350,163	TotalRevenueColumnAmt
Exclusion	$350,163	ExclusionAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$61,328,208	TotalRevenueColumnAmt
Related Or Exempt Func Income	$6,639,555	RelatedOrExemptFuncIncomeAmt
Exclusion	$514,568	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$15,306,919	TotalAmt
Program Services	$15,306,919	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$2,292,243	TotalAmt
Program Services	$2,292,243	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$2,038,108	TotalAmt
Program Services	$1,221,969	ProgramServicesAmt
Management And General	$816,139	ManagementAndGeneralAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$16,670,043	TotalAmt
Program Services	$12,724,620	ProgramServicesAmt
Management And General	$3,945,423	ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$1,405,104	TotalAmt
Program Services	$1,014,521	ProgramServicesAmt
Management And General	$390,583	ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$3,738,990	TotalAmt
Program Services	$2,699,645	ProgramServicesAmt
Management And General	$1,039,345	ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$1,282,925	TotalAmt
Program Services	$926,304	ProgramServicesAmt
Management And General	$356,621	ManagementAndGeneralAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$26,239	TotalAmt
Management And General	$26,239	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$93,798	TotalAmt
Management And General	$93,798	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Field	Value	IRS element (for citing)
Fees For Services Prof Fundraising		FeesForServicesProfFundraising

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$1,906,657	TotalAmt
Program Services	$1,120,536	ProgramServicesAmt
Management And General	$786,121	ManagementAndGeneralAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$297,252	TotalAmt
Management And General	$297,252	ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$194,207	TotalAmt
Program Services	$78,285	ProgramServicesAmt
Management And General	$115,922	ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$1,214,790	TotalAmt
Program Services	$271,907	ProgramServicesAmt
Management And General	$942,883	ManagementAndGeneralAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$2,722,498	TotalAmt
Program Services	$2,403,867	ProgramServicesAmt
Management And General	$318,631	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$297,778	TotalAmt
Program Services	$264,578	ProgramServicesAmt
Management And General	$33,200	ManagementAndGeneralAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$115,644	TotalAmt
Program Services	$95,466	ProgramServicesAmt
Management And General	$20,178	ManagementAndGeneralAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$830,874	TotalAmt
Program Services	$731,170	ProgramServicesAmt
Management And General	$99,704	ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$3,232,688	TotalAmt
Program Services	$2,618,059	ProgramServicesAmt
Management And General	$614,629	ManagementAndGeneralAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$42,774	TotalAmt
Management And General	$42,774	ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt
Supplies	$5,954,408	$5,873,296	$81,112
Other Purchased Services	$269,993	$195,506	$74,487
Patient Costs	$1,042,201	$1,042,201
Research Participants Fee	$434,663	$434,637	$26

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$493,610	TotalAmt
Program Services	$174,235	ProgramServicesAmt
Management And General	$319,375	ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$61,904,406	TotalAmt
Program Services	$51,489,964	ProgramServicesAmt
Management And General	$10,414,442	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$7,908,388	BOYAmt
EOY	$9,549,793	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$738,315	BOYAmt
EOY	$747,735	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$9,220,049	BOYAmt
EOY	$11,311,167	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$389,852	BOYAmt
EOY	$314,740	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$302,375	BOYAmt
EOY	$505,401	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$67,900,499	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$35,596,413	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$32,861,320	BOYAmt
EOY	$32,304,086	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$8,350,523	BOYAmt
EOY	$8,505,508	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$21,942,003	BOYAmt
EOY	$21,252,233	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$1,057,865	BOYAmt
EOY	$899,670	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$82,770,690	BOYAmt
EOY	$85,390,333	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$7,491,442	BOYAmt
EOY	$10,220,796	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$2,617,480	BOYAmt
EOY	$4,074,559	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$10,075,000	BOYAmt
EOY	$9,755,000	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$19,871,490	BOYAmt
EOY	$19,296,490	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$40,055,412	BOYAmt
EOY	$43,346,845	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$23,916,255	BOYAmt
EOY	$24,026,666	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$9,702,544	BOYAmt
EOY	$8,864,453	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$9,096,479	BOYAmt
EOY	$9,152,369	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$42,715,278	BOYAmt
EOY	$42,043,488	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$82,770,690	BOYAmt
EOY	$85,390,333	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	-$576,198	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$140,592	NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts	$45,000	DonatedServicesAndUseFcltsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Separate Basis Fincl Stmt	Yes (X)	SeparateBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	Yes (true)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (true)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Medical Research Organization	Yes (X)	MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp

Supported Organization Name SupportedOrganizationName

Field	Value	IRS element (for citing)
Business Name Line1	Virginia Mason Medical Center	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$29,756,050	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$34,328,409	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$38,329,362	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$44,973,133	CurrentTaxYearMinus1YearAmt
Current Tax Year	$54,219,085	CurrentTaxYearAmt
Total	$201,606,039	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$29,756,050	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$34,328,409	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$38,329,362	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$44,973,133	CurrentTaxYearMinus1YearAmt
Current Tax Year	$54,219,085	CurrentTaxYearAmt
Total	$201,606,039	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$29,779,658	SubstantialContributorsTotAmt
Public Support Total170	$171,826,381	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$1,644,044	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$1,724,806	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$560,734	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$642,011	CurrentTaxYearMinus1YearAmt
Current Tax Year	$707,157	CurrentTaxYearAmt
Total	$5,278,752	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$2,423,158	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$2,391,006	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$4,701,834	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$6,122,655	CurrentTaxYearMinus1YearAmt
Current Tax Year	$6,639,555	CurrentTaxYearAmt
Total	$22,278,208	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$229,162,999	TotalSupportAmt
Public Support CY170	0.74980	PublicSupportCY170Pct
Public Support PY170	0.72700	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind
Public Support CY509	0.00000	PublicSupportCY509Pct
Investment Income CY	0.00000	InvestmentIncomeCYPct

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Organization Belongs Afflt Grp	Yes (X)	OrganizationBelongsAffltGrpInd

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

Field	Value	IRS element (for citing)
Affiliated Group Total	$119,335	AffiliatedGroupTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

Field	Value	IRS element (for citing)
Affiliated Group Total	$19,500	AffiliatedGroupTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Affiliated Group Total	$138,835	AffiliatedGroupTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$61,904,406	FilingOrganizationsTotalAmt
Affiliated Group Total	$1,056,494,119	AffiliatedGroupTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$61,904,406	FilingOrganizationsTotalAmt
Affiliated Group Total	$1,056,632,954	AffiliatedGroupTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$1,000,000	FilingOrganizationsTotalAmt
Affiliated Group Total	$1,000,000	AffiliatedGroupTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$250,000	FilingOrganizationsTotalAmt
Affiliated Group Total	$250,000	AffiliatedGroupTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$1,000,000	CurrentYearMinus3Amt
Current Year Minus2	$1,000,000	CurrentYearMinus2Amt
Current Year Minus1	$1,000,000	CurrentYearMinus1Amt
Current Year	$1,000,000	CurrentYearAmt
Total	$4,000,000	TotalAmt

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$222,311	CurrentYearMinus3Amt
Current Year Minus2	$133,874	CurrentYearMinus2Amt
Current Year Minus1	$122,035	CurrentYearMinus1Amt
Current Year	$138,835	CurrentYearAmt
Total	$617,055	TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$250,000	CurrentYearMinus3Amt
Current Year Minus2	$250,000	CurrentYearMinus2Amt
Current Year Minus1	$250,000	CurrentYearMinus1Amt
Current Year	$250,000	CurrentYearAmt
Total	$1,000,000	TotalAmt

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$122,311	CurrentYearMinus3Amt
Current Year Minus2	$127,874	CurrentYearMinus2Amt
Current Year Minus1	$114,035	CurrentYearMinus1Amt
Current Year	$119,335	CurrentYearAmt
Total	$483,555	TotalAmt

Field	Value	IRS element (for citing)
Volunteers	false	VolunteersInd
Paid Staff Or Management	false	PaidStaffOrManagementInd
Media Advertisements	false	MediaAdvertisementsInd
Mailings Members	false	MailingsMembersInd
Publications Or Broadcast	false	PublicationsOrBroadcastInd
Grants Other Organizations	false	GrantsOtherOrganizationsInd
Direct Contact Legislators	false	DirectContactLegislatorsInd
Rallies Demonstrations	false	RalliesDemonstrationsInd
Other Activities	false	OtherActivitiesInd
Not Described Section501c3	false	NotDescribedSection501c3Ind
Form4720 Filed4912 Tax	false	Form4720Filed4912TaxInd

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
II-A A	Benaroya Research Institute at Virginia Mason, EIN 91-0653422, 1201 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0.
II-A A continued	Virginia Mason Health System, EIN 91-1351110, 1100 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0.
II-A A continued	Virginia Mason Institute, EIN 26-3763656, 1100 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0.
II-A A continued	Virginia Mason Medical Center, EIN 91-0565539, 1100 Ninth Avenue, Seattle, WA 98101. Electing Member. Grassroots Lobbying Expenditures 119,335. Direct Lobbying Expenditues 19,500. Excess Lobbying Expenditures 0. Tax year ending December 31, 1998 was the first year in which Virginia Mason Medical Center made the election under Section 501h. The election was not revoked before the start of the tax year ending December 31, 2014.

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Incl Escrow Custodial Acct Liab	false	InclEscrowCustodialAcctLiabInd
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	Yes (true)	EndowmentsHeldRelatedOrgInd
Related Org List Sch R	Yes (true)	RelatedOrgListSchRInd

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$756,906	OtherCostOrOtherBasisAmt
Book Value	$756,906	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$48,213,776	OtherCostOrOtherBasisAmt
Depreciation	$21,049,090	DepreciationAmt
Book Value	$27,164,686	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$196,862	OtherCostOrOtherBasisAmt
Depreciation	$196,862	DepreciationAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$18,638,013	OtherCostOrOtherBasisAmt
Depreciation	$14,350,461	DepreciationAmt
Book Value	$4,287,552	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$94,942	OtherCostOrOtherBasisAmt
Book Value	$94,942	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$32,304,086	TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp (3 entries)

DescDesc	Book ValueBookValueAmt	Method ValuationMethodValuationCd
Financial derivatives and other financial products
Closely-held equity interests
Interest in Net Assets of Virginia Mason Health System	$21,252,233	F

Field	Value	IRS element (for citing)
Total Book Value Securities	$21,252,233	TotalBookValueSecuritiesAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	Federal income taxes	Desc

Field	Value	IRS element (for citing)
Total Rev Etc Audited Fincl Stmt	$61,232,616	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$140,592	NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts	$45,000	DonatedServicesAndUseFcltsAmt
Revenue Not Reported	-$95,592	RevenueNotReportedAmt
Revenue Subtotal	$61,328,208	RevenueSubtotalAmt
Total Revenue Per Form990	$61,328,208	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$61,904,406	TotExpnsEtcAuditedFinclStmtAmt
Expenses Subtotal	$61,904,406	ExpensesSubtotalAmt
Total Expenses Per Form990	$61,904,406	TotalExpensesPerForm990Amt

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
East Asia and the Pacific	Conferences	Medical Research	$3,710
Europe Including Iceland and Greenland	Conferences	Medical Research	$23,320

Field	Value	IRS element (for citing)
Subtotal Spent	$27,030	SubtotalSpentAmt
Total Spent	$27,030	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (3 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
Europe Including Iceland and Greenland	Medical Research	$1,954,683	Wire Transfer
North America	Medical Research	$244,795	Wire Transfer
East Asia and the Pacific	Medical Research	$92,764	Wire Transfer

Field	Value	IRS element (for citing)
Total Other Org	15	TotalOtherOrgCnt
Transfer To Foreign Corp	false	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	false	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line 2	Subrecipient Monitoring Policy - medical research sub awards - BRI has formal policies and procedures to assure full compliance with applicable policies and laws governing Federal Grants. The Subrecipient Monitoring policy provides assurance that subrecipients comply with Federal Grant regulations. This policy sets the criteria to establish eligibility of subrecipients to provide annual audited financial reports and the annual OMB single audit report that identify compliance with federal laws and regulations. The reports are analyzed with emphasis on auditors assessement of subrecipient internal controls and a standardized Risk Assessment is presented to management on each subrecipient. A Management Letter is issued to each subrecipient showing any findings on their OMB single audit report, and measurements are set for increased monitoring when an elevated level of risk is established. Management has communicated with an educated administrative staff regarding implementation of this policy. The Director of Grants and Contracts is responsible for monitoring subrecipient adherence to financial regulations. The principal investigator is responsible for overseeing the satisfactory performance of the sub-award to ensure that goals are achieved. If there are unusual or unforeseen items, these will be investigated.
Part I Line 3f	The expenditures were actual expenses incurred in the region based on individual expense reports and tracking of expenditures by grant or department on the accrual basis of accounting.
Part II Line 1	The expenditures were expenses incurred in the region based on award goals on the accrual basis of accounting.

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (60 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt	IRC SectionIRCSectionDesc
Adaptive Biotechnologies
1551 Eastlake Ave S Suite 200	Seattle	WA	98102	270907024	$43,384	Medical Research
Ann & Robert H Lurie Children's Hospital of Chicago
225 East Chicago Ave No 205	Chicago	IL	606112991	362170833	$30,155	Medical Research	501c3
Arkansas Children's Hospital Research Institute
Slot 663 One Childrens Way	Little Rock	AR	722023591	710694931	$156,665	Medical Research	501c3
Asthma Inc
9725 3rd Aven NE Suite 500	Seattle	WA	98115	237219813	$35,064	Medical Research	501c3
Blood Systems Research Institute
270 Masonic Ave	San Francisco	CA	94118	860098929	$87,730	Medical Research	501c3
The Brigham and Women's Hospital Inc
101 Huntington Avenue Suite 300	Boston	MA	02199	042312909	$92,628	Medical Research	501c3
California Institute of Technology
1200 E California Blvd	Pasadena	CA	91125	951643307	$45,612	Medical Research	501c3
Cedars-Sinai Medical Center
8700 Beverly Blvd Suite 1150	Los Angeles	CA	900481804	951644600	$186,725	Medical Research	501c3
Childrens Hospital Los Angeles
4650 Sunset Blvd	Los Angeles	CA	90027	951690977	$21,152	Medical Research	501c3
Children's Mercy Hospital
2401 Gillham Road	Kansas City	MO	64101	440605373	$19,046	Medical Research	501c3
Columbia University
PO Box 29789 General Post Office	New York	NY	100879789	135598093	$35,252	Medical Research	501c3
Creighton University
2500 California Plaza	Omaha	NE	68178	470376583	$13,927	Medical Research	501c3
Duke University
PO Box 602651	Charlotte	NC	282602651	560532129	$207,116	Medical Research	501c3
Emory University
101 Woodruff Circle - 7126 WMRB	Atlanta	GA	30322	580566256	$197,523	Medical Research	501c3
Feinstein Institute for Medical Research
972 Brush Hollow Rd	Westbruy	NY	11590	112673595	$60,158	Medical Research	501c3
Fred Hutchinson Cancer Research Center
1100 Fairview Ave N	Seattle	WA	98109	237156071	$62,208	Medical Research	501c3
Icahn School of Medicine at Mount Sinai
One Gustave L Levy Place Box 3500	New York	NY	100296574	136171197	$174,353	Medical Research	501c3
Indiana University
400 3 7th St Poplars Room 501	Bloomington	IN	47405	356001673	$45,930	Medical Research	501c3
John Hopkins University
12529 Collections Center Drive	Chicago	IL	60693	520595110	$319,979	Medical Research	501c3
Lab Key Software
617 Eastlake Ave E 400	Seattle	WA	98109	208266728	$119,134	Medical Research
La Jolla Institute for Allergy & Immunology
9420 Athena Circle	La Jolla	CA	92037	330328688	$54,118	Medical Research	501c3
Louisana State University Health Sciences Center at Shreveport
1501 Kings Highway	Shreveport	LA	711303932	720702002	$15,277	Medical Research	Louisana
Massachusetts General Hospital
55 Fruit Street Research Management	Boston	MA	02114	042697983	$3,971,129	Medical Research	501c3
National Jewish Health
1400 Jackson Street M213	Denver	CO	80206	742044647	$44,054	Medical Research	501c3
New York University-School of Medicine
PO Box 415026	Boston	MA	022415026	135562308	$27,232	Medical Research	501c3
Northwestern University
645 N Michigan Ave Suite 530	Chicago	IL	60611	362167817	$35,107	Medical Research	501c3
Norton Neurosciences Institute
224 East Broadway 7th Floor	Louiseville	KY	402022025	611276316	$8,910	Medical Research	501c3
Oklahoma Medical Research Foundation
825 NE 13th Street	Oklahoma City	OK	73104	730580274	$104,459	Medical Research	501c3
The Research Insitute at Nationwide
PO Box 715245	Columbus	OH	432715245	316056230	$107,821	Medical Research	501c3
Rockefeller University
1230 York Ave	New York	NY	100656307	131624158	$115,948	Medical Research	501c3
Rogosin Institute
504 East 74th St 5th Floor	New York	NY	100214782	133184198	$63,560	Medical Research	501c3
Rutgers the State University of New Jersey
3 Rutgers Plaza	New Brunswick	NJ	089018559	226001086	$257,701	Medical Research	501c3
Sanford Research
2301 E 60th St N	Sioux Falls	SD	57104	460450378	$13,513	Medical Research	501c3
Seattle Childrens Hospital
PO Box 24728	Seattle	WA	981240728	910564748	$953,537	Medical Research	501c3
South Suburban Neurology
3235 Vollmer Rd 110	Flossmoor	IL	60422	330142574	$38,265	Medical Research
Stanford University
3160 Porter Drive Suite 100	Palo Alto	CA	943048445	941156365	$870,882	Medical Research	501c3
Sutter East Bay Hospitals
PO Box 742585	Los Angeles	CA	900742585	941196176	$18,193	Medical Research	501c3
Swedish Health Services
PO Box 94085	Seattle	WA	981249845	910433740	$6,820	Medical Research	501c3
University of South Florida
PO Box 864568	Orlando	FL	328864568	593102112	$6,883	Medical Research	Florida
University of Washington
12455 Collections Drive	Chicago	IL	606930001	916001537	$1,006,139	Medical Research	Washington
University of Colorado-Denver
PO Box 910238	Denver	CO	802910238	846000555	$165,384	Medical Research	501c3
University of Massachusetts Medical School
BioLabs Bursar Office	Worcester	MA	01655	043167352	$27,799	Medical Research	Massachusetts
University of Iowa
2 Gilmore Hall	Iowa City	IA	52242	426004813	$19,817	Medical Research	Iowa
University of Kentucky Research Foundation
PO Box 931113	Cleveland	OH	44193	616033693	$33,490	Medical Research	501c3
Unversity of California
Box 0897	San Francisco	CA	941430897	946002123	$1,350,081	Medical Research	501c3
University of Pennsylvania
3451 Walnut St Rm P-221	Philadelphia	PA	191046205	231352685	$69,371	Medical Research	501c3
University of California San Diego
9500 Gilman Drive	La Jolla	CA	920930009	956006144	$21,583	Medical Research	501c3
University of Florida
PO Box 113001	Gainesville	FL	32611	596002052	$274,061	Medical Research	501c3
University of Nebraska Medical Center
985045 Nebraska Medical Center	Omaha	NE	681985045	470049123	$151,766	Medical Research	501c3
University of Arizona
PO Box 3520	Tucson	AZ	857223520	742652689	$14,671	Medical Research	Arizona
University of Maryland Baltimore
220 Arch Street	Baltimore	MD	212011508	526002033	$33,758	Medical Research	Maryland
University of North Carolina at Chapel Hill
104 Airport Drive Suite 2200 CB1350	Chapel Hill	NC	27599	566001393	$481,280	Medical Research	501c3
University of Massachusetts Worcester
55 Lake Avenue North	Worcester	MA	016550002	043167352	$19,535	Medical Research	Massachusetts
University of California Davis
PO Box 989062	West Sacramento	CA	957989062	946036494	$26,099	Medical Research	501c3
University of Chicago
5841 S Maryland Ave MC 5030	Chicago	IL	60637	362177139	$20,352	Medical Research	501c3
University of California San Francisco
3333 California St Ste 315	San Francisco	CA	941430962	946036493	$2,628,719	Medical Research	501c3
University of Washington
4333 Brooklyn Ave NE Box 359472	Seattle	WA	98195	916001537	$5,163	Medical Research	Washington
University of Pittsburgh
PO Box 371220	Pittsburg	PA	152517220	250965591	$40,621	Medical Research	501c3
University of Michigan
Box 223131 SSC	Pittsburgh	PA	152512131	386006309	$6,926	Medical Research	501c3
Yale University
PO Box 1873	New Haven	CT	065081873	060648973	$229,386	Medical Research	501c3

Field	Value	IRS element (for citing)
Total501c3 Org	57	Total501c3OrgCnt
Total Other Org	3	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Part I Line 2	FormAndLineReferenceDesc
Explanation	Subrecipient Monitoring Policy - medical research sub awards - BRI has formal policies and procedures to assure full compliance with applicable policies and laws governing Federal Grants. The Subrecipient Monitoring policy provides assurance that subrecipients comply with Federal Grant regulations. This policy sets the criteria to establish eligibility of subrecipients and requires subrecipients to provide both annual audited financial reports and the annual OMB single audit report that identify compliance with federal laws and regulations. The reports are analyzed with emphasis on auditors assessment of subrecipient internal controls and a standardized Risk Assessment is presented to management on each subrecipient. A Management Letter is issued to each subrecipient showing any findings on their OMB single audit report, and measurements are set for increased monitoring when an elevated level of risk is established. Management has communicated with an educated administrative staff regarding implementation of this policy. The Director of Grants and Contracts is responsible for monitoring subrecipient adherence to financial regulations. The principal investigator is responsible for overseeing the satisfactory performance of the sub-award to ensure that goals are achieved. If there are unusual or unforeseen items, these will be investigated.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
First Class Or Charter Travel	Yes (X)	FirstClassOrCharterTravelInd
Written Policy Ref T And E Expnss	Yes (true)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (true)	SubstantiationRequiredInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (true)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	false	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt
Carla Greenbaum MD
Director	$210,249	$900	$23,000	$6,898	$241,047
Gerald Nepom MD PhD
Ex Officio, Director	$386,087	$126,458	$40,496	$2,592	$555,633
Joyce Lammert MD PhD
Director						$441,642	$119,973	$18,737	$110,676	$11,890	$702,918
John Corman MD
Director						$466,260		$17,770	$46,077	$21,930	$552,037
Gary Kaplan MD
Director						$1,026,920	$425,070	$18,737	$2,051,237	$41,193	$3,563,157
Homer Lane Jr
Executive Director and Chief Financial Officer	$241,807	$77,885	$13,000	$8,394	$341,086
Jane Buckner MD
Research Member	$225,896		$23,000	$2,892	$251,788
William Kwok PhD
Research Member	$206,984	$926	$23,000	$5,652	$236,562
Steven Ziegler PhD
Research Member	$177,752	$526	$14,012	$9,384	$201,674
Thomas Wight PhD
Research Member	$161,407	$526	$23,000	$14,808	$199,741
Lynn Rose PhD
Director Scientific Administration	$174,803	$526	$18,042	$5,092	$198,463

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

Part I Line 3

Benaroya Ressearch Institute at Virginia Mason relies upon Virginia Mason Medical Centers a related organization Board Compensation and Benefits Committee, a committee composed of independent board members to whom the Board has delegated the authority to approve all compensation and benefits for the executive leaders of the Medical center. to ensure that such benefit plans are market competitive and reasonable, the Committee receives support and advice, including appropriate market comparability data, from an independent compensation consultant with expertise in the health care industry and access to relevant market data. See Schedule O for additional disclosure.

Part I Line 4b

The Medical Center has a Supplemental Executive Retirement Plan SERP. The SERP is a 457f nonqualified deferred compensation plan pursuant to which plan benefits are subject to a substantial risk of forfeiture, entered into when certain senior executives join the Medical Center. The plan was approved by the Boards Compensation and Benefits Committee, a committee composed of independent board members to whom the board delegates the authority to approve compensation and benefits for the Medical Centers most senior executives. the Committee receives advice from an independent compensation consultant to ensure that compensation and benefits, including the SERP, are market competitve and reasonable.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	WA Econ Devel Fin Auth-2012 Series B	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Bond Issuer EIN	911493002	BondIssuerEIN
Bond Issued	2012-06-01	BondIssuedDt
Issue Price	$10,390,000	IssuePriceAmt
Purpose	See Part VI	PurposeDesc
Defeased	false	DefeasedInd
On Behalf Of Issuer	Yes (true)	OnBehalfOfIssuerInd
Pool Financing	false	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Retired	$635,000	RetiredAmt
Total Proceeds	$10,390,348	TotalProceedsAmt
Capital Expenditures	$2,550,348	CapitalExpendituresAmt
Other Spent Proceeds	$7,840,000	OtherSpentProceedsAmt
Substantial Completion	2013	SubstantialCompletionYr
Current Refunding	Yes (true)	CurrentRefundingInd
Advance Refunding	false	AdvanceRefundingInd
Final Allocation Made	Yes (true)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (true)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	false	OwningBondFinancedPropertyInd
Any Lease Arrangements	Yes (true)	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	false	MgmtContractBondFincdPropInd
Any Research Agreements	Yes (true)	AnyResearchAgreementsInd
Engage Bond Counsel Research	Yes (true)	EngageBondCounselResearchInd
Private Bus Use By Others	0.01290	PrivateBusUseByOthersPct
Total Private Business Use	0.01290	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	false	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	false	ChangeInUseBondFinancedPropInd
Procs Nonqualified Bond Remdtd	Yes (true)	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	false	Form8038TFiledInd
Rebate Not Due Yet	Yes (true)	RebateNotDueYetInd
Variable Rate Issue	false	VariableRateIssueInd
Hedge Identified In Bks And Rec	false	HedgeIdentifiedInBksAndRecInd
Gross Proceeds Invested In GIC	false	GrossProceedsInvestedInGICInd
Gross Proceeds Invested	false	GrossProceedsInvestedInd
Written Proc To Monitor Reqs	Yes (true)	WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Procedures Corrective Action	Yes (true)	ProceduresCorrectiveActionInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line A f	Purposes to currently refund WEDFA Series 2006C bonds issued 11/15/2006, and to fund research facility improvements.
Part II Line 3	Difference between Part I, column e and Part II, Line 3 is investment earnings.

Schedule M IRS990ScheduleM

Other Non Cash Contri Table OtherNonCashContriTableGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Desc	Advertising	Desc
Contribution	32	ContributionCnt
Noncash Contributions Rpt F990	$147,625	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Donor valuation	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	false	ReviewProcessUnusualNCGiftsInd
Third Parties Used	false	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Part I Line Column b	FormAndLineReferenceDesc
Explanation	BRI received two large bulletin displays and 30 poster displays for the BRI Awareness Campaign.	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (12 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Form 990, Part III, Line 1	Benaroya Research Institute at Virginia Mason BRI is a world-renowned medical research institute whose work has resulted in major advances against autoimmune and immune-mediated diseases. One in 20 Americans suffers from one or more autoimmune diseases, such as type 1 diabetes, multiple sclerosis, Crohns disease and rheumatoid arthritis to name a few, and more than one out of every four Americans suffer from diseases of the immune system, such as allergies and asthma. Because these diseases are connected in the way the immune system attacks the body, BRI scientists arent focused on eliminating one or two immune system diseases - they are taking on many more. As a world leader in scientific innovation, BRIs discoveries are having significant impact on people living with these diseases today - by improving the ability to predict disease risk, decreasing disease progression and making therapies safer and better.
Form 990, Part III, Line 4	One of the unique qualities of BRI is the close integration of three types of medical research - laboratory research, translational research and clinical research - to improve peoples lives. Our scientists can address both the basic science issues and clinical applications, which is the best way to design studies with the highest potential for success. For BRI, discovery starts in the laboratory. 2014 key outcomes of the Immune Tolerance Network as well as advancements in translational research, diabetes research and other areas of immunological research are highlighted below.
Form 990, Part III, Line 4a	Funding for the Immune Tolerance Network ITN was awarded to BRIs Dr. Jerry Nepom in 2014 from the National Istitute of Allergy and Infections Disease NIAID of the National Institutes of Health NIH. The 7-year award, totaling 27 million annually supports the ITN, a research consortium established in 1999 with a primary focus on the development of new tolerogenic approaches for the treatement and prevention of disease in three clinical areas asthma and allergic diseases autoimmune diseases and immune-mediated rejection of transplanted solid organs, tissues and cells. As the Prime recipient of this grant BRI is responsible for the management of the overall grant from NIAID including oversight of all aspects of the Networks infrastructure. The major activities in 2014 were diverse, but centered on preserving the ITNs cohesive project focused environment and establishing the framework necessary for successful management of a large cooperative agreement grant. Key outcomes in 2014 include the following 1 Cross Network Integration A top priority in this reporting period was to continue the successful ITN infrastructure with the funding transition over to BRI. This required careful planning and collaboration as the ITNs major centers of operations are geographically diverse, located in Seattle, San Francisco and Bethesda. As such, very few changes were made to the existing network integration, however new relations and vital connections were developed. 2 Operations and Clinical Trial Support The ITN program team at BRI issued 152 subawards in 2014 in support of 23 active ITN clinical trials and numerous supporting ITN mechanistic trials. 3 Supplemental Funding / Partnerships The transition to the cooperative agreement included a significant budget reduction to the ITNs operating budget of approximately 22. To bridge this funding shortage, ITN central administration focused on identifying additional opportunites for supplemental funding and/or funding partnerships. a Supplemental Funding Opportunities The ITN Porgram Team at BRI submitted three supplemental funding requests in 2014. All three were awarded bringing in additional funding to the ITN BRI. The ITN Program Team was also successful in its application to allow pre-clinical work by the ITN. This greatly increased the supplemental funding opportunities to which the ITN program can apply in the future. b Partnerships Finalization of agreements with pharmaceutical partners for partial funding of two ITN studies with NIAID as the clinical sponsor. 4 Publication Activity In 2014, 24 ITN publications were published in prestigious research journals and were presented at domestic and internatioinal research conferences. These publications represented ITN research in all therapeutic focus areas of the ITN Type 1 Diabetes, Transplant, Autoimmune disease and Allergy and Asthma.
Form 990, Part III, Line 4b	Translational research is a scientific approach that moves finding from the bench to the bedside and back in an expedient and systematic way. It translates new laboratory discoveries quickly into medical practices. Clinician findings are in turn shared with laboratory scientists to bring medical research full circle This transfer of knowledge between laboratory scientists and physicians leads to improved patient care, health and well-being. The research emphasis of the BRI Translational Research Program is the area of immune-mediated disease. BRI scientists and collaborators work together to study blood and serum samples along with medical and demographic data collected from people with autoimmune and immune-mediated diseases. These include multiple sclerosis, type 1 diabetes, lupus, rheumatoid arthritis, inflammatory bowel disease, allergy and asthma. BRI maintains an extensive biorepository with samples dating back to 2000, including 7 disease categories and a biorepository of healthy people for comparison purposes. Advancements in 2014 include the following 1 Scientists made discoveries that led to the isolation of a type of white blood cells that show up only in people with allergic disease. They also began work to find a unique biomarker that initiates and drives allergies. Identifying a biomarker at the top of the allergic chain reaction will help predict the onset of allergy and lead to novel vaccine approaches. This is especially important in at-risk people such as children with a life-threatening food allergy. 2 A new collaboration began in studying a critical question in type I diabetes Why do some people who get type 1 diabetes continue to produce small amounts of insulin over time while others stop Researchers have found at the time of diagnosis with type 1 diabetes that many people continue to produce small amounts of insulin. Since even small amounts of natural insulin production can decrease the long-term effects of diabetes and improve short-term clinical management, scientists search for ways to keep these remaining cells producing insulin. BRIs team of scientists is comparing the genetic and immunological factors that influence levels of insulin production in people with this disease. They intend to utilize this knowledge to develop biomarkers to monitor the immune status of people with type 1 diabetes early in their disease process. The aim would be to design a drug combination that would keep a person with type 1 diabetes producing their own insulin as long as possible. 3 New equipment was purchased that allows acceleration of research discovery through advances in technology. The next generation sequencer, Illumina HiSeq 2500, is Illuminas newest version of the HiSeq instruments and will dramatically increase the sequencing capacity and data yield of the sequencing services offered by the Genomics Core, as well as decrease the cost of sequencing for BRIs labs.
Form 990, Part III, Line 4c	BRI is dedicated to seeking ways to eliminate type 1 diabetes, while at the same time looking for therapies to prevent, reverse and intervene in the disease at all stages. BRI is an international leader in type 1 diabetes research and has investigated it for more than 30 years, starting with identification of a genetic marker for the disease. Progress in 2014 includes 1 BRI became the TrialNet Hub which supports and advocates for TrialNets clinical centers across the international network, encouraging collaboration and developing processes to streamline recruitment and clinical operations. The TrialNet Network is supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health NIH. The network includes 21 Clinical Centers working in cooperation with more than 200 screening and clinical research sites throughout the United States and seven other countries. TrialNet is dedicated to the study, prevention and early treatment of type 1 diabetes. Clinical trials have identified markers for risk and disease progression in diabetes and are testing therapies to intervene prior to onset of clinical symptoms, by blocking the immune attack on pancreatic beta cells that produce insulin. 2 BRI scientists are investigating the molecular mechanisms of the type 1 diabetes autoimmune response, and of immune interactions with each therapy, to better understand disease progression and uncover new approaches to treatment. These studies are also developing methods to better predict a persons disease risk and provide earlier diagnoses so that patients can begin treatments earlier, at a time when more beta cells remain and more of the insulin production function can be saved. Teams of BRI investigators are developing discovery pipelines for analysis of clinical trial samples to better understand the way different individuals respond to different therapies through interrogation of transcriptional and phenotypic properties of individual immune cells. This information is a cornerstone for tailoring therapy specifically to individuals - the right treatment for the right person at the right time. 3 Through analysis of metabolic and immunological profiles, the Diabetes Research Program and colleagues created new algorithms to track and predict the clinical course of type 1 diabetes, essential for developing innovative prevention and islet preservation therapies.
Form 990, Part III, Line 4d	Other Advances. 1 Laboratory studies prospered, particularly in discovering new biomarkers and mechanisms of diseases across a broad scope of immunological dysfunction. 2 Studies in allergies identified important specific molecular signals in people with allergy to shrimp and to grass pollen, which will enable personalized monitoring of people with these conditions. 3 Systems Immunology reported several innovative transcriptional profiling studies, including analysis of sepsis and systemic lupus. 4 Researchers identified a novel profile for melanoma that correlates with poor clinical outcomes related to the immunological response to the tumor. 5 Scientists characterized a new type of immunological recognition in patients with rheumatoid arthritis and type 1 diabetes. 6 The Immunology Research Program described complex interactions within T lymphocytes that determine cell lineage and fate, a balance required for normal homeostasis and immune response. 7 A new Computing Cluster for data-intense projects was launched with expanded capabilities for analysis and storage.
Form 990, Part VI, Section A, Line 1a	The governing body delegates to an Executive Committee comprised of four officers of the Board and the Chairs of each standing Board Committee, the authority of the Board of Directors in the management of the corporation as may be deemed by the Executive Committee to be appropriate, to be exercised in time periods between regularly scheduled meetings of the Board of Directors provided that the Executive Committee has the authority to act only in time sensitive or emergency situations. The Director and the Executive Director of the corporation serve as ex officio members of the Executive Committee without voting rights. The Executive Committee does not have the authority to amend, alter or repeal the bylaws elect, appoint or remove any member of such Executive Committee or any director or officer of the corporation amend the articles of incorporation adopt a plan of merger or adopt a plan of consolidation with another corporation authorize the sale, lease or exchange of all or substantially all the property and assets of the corporation not in the ordinary course of business authorize the voluntary dissolution of the corporation or revoke proceedings therefore adopt a plan for the distribution of the assets of the corporation or amend, alter or repeal any resolution of the Board which by its terms provides that it shall not be amended, altered or repealed by such Executive Committee. The Executive Committee also serves as the planning committee for the Board of Directors and oversees any compliance issues raised by the Board of Directors.
Form 990, Part VI, Section A, Line 6, 7	Virginia Mason Health System VMHS is the sole corporate member of Benaroya Research Institute at Virginia Mason BRI. VMHS as the sole voting member has the following approval rights a election or appointment of Directors and Officers of the Board of Directors b removal of Directors and Officers of the Board of Directors including any executive officer of the corporation c approval of all long-range and short-range plans proposed by the Board of Directors d approval of the annual capital and operating budgets proposed by the Board of Directors e approval of the borrowing of funds where the amount borrowed is in excess of Five Hundred Thousand Dollars 500,000 f approval of the sale, lease, exchange, mortgage, pledge or disposal of all or substantially all of the property and assets g approval of all amendments to or repeal of the Agreement Agreement Association or the Bylaws of the corporation h all other rights and powers as specified in the Washington Nonprofit Corporation Act.
Form 990, Part VI, Section B, Line 11b	The Virginia Mason Health System Audit and Compliance Committee ACC, a committee composed of independent community members has been delegated responsibility for oversight of the annual Form 990 preparation process including a selection, engagement, and review of the performance of the independent tax preparer b review of the annual draft Form 990 tax return, and c recommendation of the final Form 990 tax return for review to the BRI Board of Directors. Annually, at the September meeting, management and the tax preparer provides the ACC with an initial draft of the Form 990 and present an overview of the Form 990 preparation process. The final draft Form 990 is reviewed and approved by the ACC in November followed by a Board review of the final Form 990 prior to filing. The final Form 990 tax return is provided to each member of the Board of Directors via electronic delivery.
Form 990, Part VI, Section B, Line 12c	The Virginia Mason Health System Governance Committee has been delegated accountability for oversight of the process for disclosure, evaluation and management of conflict of interest involving any member of the Benaroya Research Institute at Virginia Mason BRI Board of Directors, executive leadership or key employees Covered Person. Pursuant to the Conflict of Interest Policy, an annual conflict of interest questionnaire is distributed to all Covered Persons. In addition, a Covered Person has an on-going duty to disclose the existence of a conflict of interest at any time an actual or potential conflict arises. Each Covered Person is required upon appointment and annually thereafter to attest to a statement that affirms that such person has a received a copy of the Conflict of Interest Policy b has read and understands the Policy c has agreed to comply with the Policy and d understands that BRI is a charitable organization and that in order to maintain its federal tax exemption must engage in activities that accomplish its tax-exempt purposes. Written disclosures are reviewed by the Governance Committee to determine if an actual or potential conflict of interest exists and if so, how it should be managed. The Covered Person is informed in writing regarding the determination the Conflict of Interest Management Plan. No Covered Person with an actual or potential conflict of interest shall engage in an activity on BRIs behalf related to the disclossed actual or potential Conflict of Interest unless such activity is permitted by the Conflict of Interest Management Plan or until the Covered Person has undertaken all steps set forth in the Management Plan to manage, reduce or eliminate the conflict. All Covered Person have a duty to disclose the existence of any actual or potential conflict of interest with respect to meeting agenda items. The Conflict of Interest Policy requires that copies of the Conflict of Interest Questionnaire be completed annually by each covered Person and any Conflict of Interest Managemenet Plan be maintained.
Form 990, Part VI, Section B, Line 15	The VMHS Compensation and Benefits board Committee, a committee composed solely of independent directors none of whom have a conflict of interest, is accountable for setting reasonable total compensation packages for each executive, officer and key employee Executive consistent with VMHS/BRIs philosophy and principles. The Committee approves annual goals and performance criteria which are used in determining merit increases and variable compensation opportunities. The Committee assesses performance against these goals. The Committee selects and engages a qualified independent compensation consultant to review and analyze the total compensation and benefits packages of the Executives. The Committee as part of its analysis obtsins from the compensation consultant appropriate comparability data including total compensation paid by similarly situated organizations for positions that are functionally comparable to each of the Executives. The Committee will consider the significant terms of the agreement with each Executive including the total compensation to be paid and the employees duties and responsibilities. Consistent with VMHS/BRIs compensation philosophy and principles, the Committee approves total compensation packages for each of the Executives based on information presented to the Committee, reasonableness and the best interest of BRI. The Committees decisions regarding compensation for each Executive are documented in written resolutions and minutes of the Committee. The Committee promptly reports its actions to the VMHS board which reports are reflected in the Boards minutes. The individual positions who were reviewed in 2014 were the Board Director, Carla Greenbaum, BRI Director, and Executive Director and Chief Financial Officer.
Form 990, Part VI, Section C, Line 19	The organizations Articles, Bylaws, Conflict of Interest Policy and financial statements are made available upon request.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Direct Controlling NADirectControllingNACd	Controlled OrganizationControlledOrganizationInd	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
Virginia Mason Health System (VMHS)
1100 Ninth Ave	Seattle	WA	98101	911351110	Fundraising	WA	Sec 501c3	7-Support General Pu	N/A	Yes (true)
Virginia Mason Medical Center
1100 Ninth Ave	Seattle	WA	98101	910565539	Health Care	WA	Sec 501c3	3-Hospital		false	VMHS

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	false	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	Yes (true)	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	Yes (true)	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	false	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (true)	SharingOfFacilitiesInd
Paid Employees Sharing	false	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	Yes (true)	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (true)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	false	TransferToOtherOrgInd
Transfer From Other Org	false	TransferFromOtherOrgInd

Affiliated Group Schedule AffiliatedGroupSchedule

Affiliated Schedule AffiliatedScheduleGrp (4 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Total Grassroots LobbyTotalGrassrootsLobbyAmt	Total Direct LobbyTotalDirectLobbyAmt	Total Lobby ExpenditureTotalLobbyExpenditureAmt	Other Exempt Purpose ExpendOtherExemptPurposeExpendAmt	Total Exempt Purpose ExpendTotalExemptPurposeExpendAmt	Lobby NontxLobbyNontxAmt	Grassroots NontxGrassrootsNontxAmt	Total Lobby Grssroot Mns NontxTotalLobbyGrssrootMnsNontxAmt	Tot Lbby Expend Mns Lobby NontxTotLbbyExpendMnsLobbyNontxAmt	Share Excess Lobby ExpendShareExcessLobbyExpendAmt	Electing OrganizationElectingOrganizationInd
Benaroya Research Institute at Virginia Mason
1201 Ninth Avenue	Seattle	WA	981012795	910653422	$0	$0	$0	$61,904,406	$61,904,406	$58,586	$14,647	$0	$0	$0
Virginia Mason Health System
1100 Ninth Avenue	Seattle	WA	98101	911351110	$0	$0	$0	$12,874,405	$12,874,405	$12,184	$3,046	$0	$0	$0
Virginia Mason Institute
1100 Ninth Avenue	Seattle	WA	98101	263763656	$0	$0	$0	$4,489,124	$4,489,124	$4,249	$1,062	$0	$0	$0
Virginia Mason Medical Center
1100 Ninth Avenue	Seattle	WA	98101	910565539	$119,335	$19,500	$138,835	$977,226,184	$977,365,019	$924,981	$231,245	$0	$0	$0	Yes (X)